Longitudinal Arrhythmic Risk Assessment Based on Ejection Fraction in Patients with Recent-Onset Nonischemic Dilated Cardiomyopathy

Background: Practice guidelines suggest the use of implantable cardioverter-defibrillators in patients with left ventricular ejection fractions (LVEF) <= 35% despite 3 to 6 months of guideline-directed medical therapy (GDMT). It remains unclear whether this strategy is appropriate for patients with dilated cardiomyopathy (DCM), who can experience reverse ventricular remodeling for up to 24 months after the initiation of GDMT. The aim of this study was to assess the longitudinal dynamic relationship between LVEF <= 35% and arrhythmic risk in patients with recent-onset nonischemic DCM on GDMT. Methods: A retrospective analysis was conducted among patients with recent-onset DCM (<= 6 months) and recent initiation of GDMT (<= 3 months) consecutively enrolled in a longitudinal registry. Risk for major ventricular arrhythmic events or sudden cardiac death was assessed in relationship to LVEF <= 35% at enrollment and 6 and 24 months after initiation of GDMT. Results: Five hundred forty-four patients met the inclusion criteria. LVEF <= 35% identified patients with increased risk for major ventricular arrhythmic events or sudden cardiac death starting from 24 months after initiation of GDMT (hazard ratio, 2.126; 95% CI, 1.065-4.245; P = .03). However, LVEF <= 35% at presentation or 6 months after enrollment did not have prognostic significance. Sixty-seven percent of 131 patients with LVEF <= 35% at 6 months after initiation of GDMT had improved LVEFs (to >35%) by 24 months. This late LVEF improvement correlated with lower arrhythmic risk (P = .012) and was preceded by a reduction of LV dimensions in the first 6 months of GDMT. Conclusions: In patients with DCM, the present findings suggest that risk stratification for major ventricular arrhythmic events or sudden cardiac death on the basis of LVEF <= 35% is effective after 2 years of GDMT, but not after 6 months. In selected patients with DCM, it would be appropriate to wait 24 months before primary prevention ICD implantation

Automated summary

In patients with dilated cardiomyopathy (DCM), stratifying the risk for major ventricular arrhythmic events or sudden cardiac death based on left ventricular ejection fraction (LVEF) <= 35% is effective after 2 years of guideline-directed medical therapy (GDMT), but not after 6 months. Waiting 24 months before primary prevention ICD implantation may be appropriate for selected DCM patients.